EIR GlaxoSmithKline Jun 2007

Thomas Berry FDA, Burnell Henry FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observation (via FDA 483) on 12 Jun 2007.

Product details

  • Category:
  • Inspection end: 12 Jun 2007
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart
GlaxoSmithKline FDA inspection 483 Jun 2007Add To Cart

Related Product

GlaxoSmithKline 483 Apr 2016

GlaxoSmithKline 483 Apr 2016

$119.00 - Available for Instant DownloadIssued: 21 Apr 2016Type: GlaxoSmithKline - Zebulon, NC, United States
Add to Cart
GlaxoSmithKline EIR Aug 2009

GlaxoSmithKline EIR Aug 2009

$595.00 - Available for Instant DownloadIssued: 24 Aug 2009Type: GlaxoSmithKline - Zebulon, NC, United States
Add to CartAdd Top 2
GlaxoSmithKline 483 Jun 2006

GlaxoSmithKline 483 Jun 2006

$119.00 - Available for Instant DownloadIssued: 16 Jun 2006Type: GlaxoSmithKline - Zebulon, NC, United States
Add to CartAdd Top 3
GlaxoSmithKline EIR Apr 2003

GlaxoSmithKline EIR Apr 2003

$595.00 - Available for Instant DownloadIssued: 17 Apr 2003Type: GlaxoSmithKline - Zebulon, NC, United States
Add to CartAdd Top 4See Document Services Plans
GlaxoSmithKline EIR Oct 2002

GlaxoSmithKline EIR Oct 2002

$595.00 - Available for Instant DownloadIssued: 17 Oct 2002Type: GlaxoSmithKline - Zebulon, NC, United States
Add to CartAdd Top 5See Document Services Plans
GlaxoSmithKline 483 Apr 2000

GlaxoSmithKline 483 Apr 2000

$119.00 - Available for Instant DownloadIssued: 24 Apr 2000Type: GlaxoSmithKline - Zebulon, NC, United States
Add to CartAdd AllSee Document Services Plans